Radiotherapy (RT) to the primary tumour for men with newly-diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE

被引:0
|
作者
Parker, C. C. [1 ]
James, N. D. [2 ]
Brawley, C. [3 ]
Clarke, N. W. [4 ,5 ]
Attard, G. [6 ,7 ]
Chowdhury, S. [8 ]
Cross, W. [9 ]
Dearnaley, D. P. [10 ]
Gilson, C. E. [3 ]
Jones, R. [11 ]
Mason, M. D. [12 ]
Millman, R. [13 ]
Gillessen, S. [14 ,15 ,16 ]
Eswar, C. [17 ]
Gale, J. [18 ]
Lester, J. [20 ]
Sheehan, D. [19 ]
Tran, A. [20 ]
Parmar, M. K. [3 ]
Sydes, M. R. [3 ]
机构
[1] Royal Marsden NHS Fdn Trust, Inst Canc Res, Urol, Sutton, Surrey, England
[2] Queen Elizabeth Univ Hosp Birmingham NHS Fdn Trus, Clin Trials Unit, Birmingham, W Midlands, England
[3] UCL, Inst Clin Trials & Methodol, MRC Clin Trials Unit, London, England
[4] NGS Fdn Trust, Christie Hosp, Manchester, Lancs, England
[5] NGS Fdn Trust, Salford Royal Hosp, Manchester, Lancs, England
[6] Inst Canc Res, Med Oncol, London, England
[7] Royal Marsden, London, England
[8] Guys & St Thomas Hosp NHS Trust, London, England
[9] LIMM, Dept Urol, Leeds, W Yorkshire, England
[10] Inst Canc Res, London, England
[11] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland
[12] Velindre Hosp, Velindre Canc Ctr, Cardiff, S Glam, Wales
[13] MRC, Clin Trials Unit, London, England
[14] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[15] Christie, Manchester, Lancs, England
[16] Univ Bern, Kantonsspital St Gallen, Div Med Oncol & Haematol, Bern, Switzerland
[17] Clatterbridge Canc Ctr, Liverpool, Merseyside, England
[18] St Marys Hosp, Portsmouth Oncol Ctr, Portsmouth, Hants, England
[19] Royal Devon & Exeter Hosp, Exeter Oncol Ctr, Exeter, Devon, England
[20] Christie NHS Fdn Trust, Manchester, Lancs, England
基金
英国医学研究理事会;
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LBA5_PR
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Radiotherapy (RT) to the primary tumour for men with newly- diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE (NCT00268476)
    Parker, Christopher C.
    James, Nicholas D.
    Brawley, Chris
    Clarke, Noel W.
    Attard, Gerhardt
    Chowdhury, Simon
    Cross, Bill
    Gilson, Clare
    Jones, Robert J.
    Millman, Robin
    Dearnaley, David P.
    Mason, Malcolm D.
    Ritchie, Alastair
    Russell, J. Martin
    Ali, Syed Adnan
    Eswar, Chinnamani
    Gale, Joanna
    Hoyle, Alex
    Lester, Jason
    Sheehan, Denise
    Tran, Anna
    Gillessen, Silke
    Amos, Claire
    Parmar, Mahesh K. B.
    Sydes, Matthew R.
    [J]. BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 37 - 37
  • [2] Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE)
    Kretschmer, Alexander
    Gleave, Martin E.
    [J]. EUROPEAN UROLOGY, 2019, 75 (04) : 692 - 693
  • [3] Report from the ESMO 2018 presidential symposium-Radiotherapy to the primary tumour for men with newly diagnosed metastatic prostate cancer: survival results from STAMPEDE
    Parker, Chris
    [J]. ESMO OPEN, 2018, 3 (06)
  • [4] Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
    Parker, Christopher C.
    James, Nicholas D.
    Brawley, Christopher D.
    Clarke, Noel W.
    Hoyle, Alex P.
    Ali, Adnan
    Ritchie, Alastair W. S.
    Attard, Gerhardt
    Chowdhury, Simon
    Cross, William
    Dearnaley, David P.
    Gillessen, Silke
    Gilson, Clare
    Jones, Robert J.
    Langley, Ruth E.
    Malik, Zafar I.
    Mason, Malcolm D.
    Matheson, David
    Millman, Robin
    Russell, J. Martin
    Thalmann, George N.
    Amos, Claire L.
    Alonzi, Roberto
    Bahl, Amit
    Birtle, Alison
    Din, Omar
    Douis, Hassan
    Eswar, Chinnamani
    Gale, Joanna
    Gannon, Melissa R.
    Jonnada, Sai
    Khaksar, Sara
    Lester, Jason F.
    O'Sullivan, Joe M.
    Parikh, Omi A.
    Pedley, Ian D.
    Pudney, Delia M.
    Sheehan, Denise J.
    Srihari, Narayanan Nair
    Tran, Anna T. H.
    Parmar, Mahesh K. B.
    Sydes, Matthew R.
    [J]. LANCET, 2018, 392 (10162): : 2353 - 2366
  • [5] Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): a Randomised Controlled Phase 3 Trial
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2019, 202 (01): : 32 - 33
  • [6] Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial
    Tilki, Derya
    Evans, Christopher P.
    [J]. EUROPEAN UROLOGY, 2019, 75 (03) : 535 - 536
  • [7] Radiotherapy to the Primary Tumour for Patients with Metastatic Prostate Cancer: Practice-Changing Results from STAMPEDE
    Malik, Z. I.
    Fenwick, J. D.
    [J]. CLINICAL ONCOLOGY, 2020, 32 (05) : 327 - 329
  • [8] Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer
    Scott C. Morgan
    Oliver E. Holmes
    Julia Craig
    Scott Grimes
    Shawn Malone
    [J]. Prostate Cancer and Prostatic Diseases, 2021, 24 : 1041 - 1047
  • [9] Long-term outcomes of prostate radiotherapy for newly-diagnosed metastatic prostate cancer
    Morgan, Scott C.
    Holmes, Oliver E.
    Craig, Julia
    Grimes, Scott
    Malone, Shawn
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 1041 - 1047
  • [10] Management of newly-diagnosed metastatic prostate cancer
    Crawford, ED
    Boccon-Gibod, L
    Bruchovsky, N
    Iversen, P
    Kirk, D
    Kitamura, T
    Klein, E
    Mc Kiel, C
    Labrie, F
    McConnell, JD
    Vargas, R
    [J]. PROSTATE CANCER, 2000, : 351 - 394